TenderDekho Logo
Active GEM

Indian Army Department Of Military Affairs Pharmaceutical Tender 2026 - Oncology Drugs & Medical Supplies, Location Not Specified

Bid Publish Date

01-Sep-2026, 10:40 am

Bid End Date

14-Sep-2026, 11:00 am

Value

₹1,86,56,312

Generate Docs

Progress

Issue01-Sep-2026, 10:40 am
Corrigendum11-Sep-2026
AwardPending

Tender Overview

The Indian Army, Department Of Military Affairs, invites bids for a broad Pharma/Medical Supplies package valued at ₹18,656,311.48 with 55 BOQ items. The procurement encompasses numerous chemotherapy agents, antiemetics, hormonal therapies, monoclonal antibodies, analgesics, patches, and related injectable/oral formulations. The location is not specified. A key bid clause allows a ±25% quantity variation at contract award and within the currency of the contract, with delivery timelines linked to the original delivery period. Bidders must demonstrate at least 3 years of residual market life for offered products and maintain supplier continuity. Bidders must also provide a product Data Sheet and comply with GST/EFT documentation. Unique risk controls include OEM Manufacturer Authorization where applicable and ensuring products are not near end-of-life during the bid window.

Keywords integrated: tender in location, Indian Army procurement, 3 years residual market life, OEM authorization, data sheet submission, GST compliance, price variation option, 25% quantity flex, data sheet verification, central government supplier.

Technical Specifications & Requirements

  • Product scope includes a wide range of injectable and oral oncology and supportive care medicines, patches, and related delivery systems.
  • Data Sheet requirement: upload product data sheets and ensure alignment with offered parameters.
  • Experience requirement: bidder or OEM must have supplied similar Category Products to Central/State Govt/PSU for 3 years before bid opening.
  • Manufacturer Authorization: OEM/distributor authorization form required with contact details.
  • GST/EFT documentation: GSTIN copy and EFT mandate, cancelled cheque must be provided, GST uploaded on GeM invoice.
  • Delivery option clause: quantity may be increased/decreased by up to 25%; extended delivery time formula applies with minimum 30 days.
  • Quality/Compliance: ensure products are not end-of-life during the bid period; verify data against parameters.

Terms, Conditions & Eligibility

  • EMD: Not specified in provided terms; ensure clarity during bid submission.
  • Experience/Turnover: 3 years of regular manufacturing/supplying similar products to govt bodies; provide relevant contract copies.
  • Delivery & Payment: delivery schedule tied to original/extended delivery periods; payment terms not detailed in data.
  • Documents: PAN, GSTIN, cancelled cheque, EFT mandate, OEM authorization, and product Data Sheets.
  • GST: GST payable as per actuals or applicable rates, with GST re-imbursement subject to rates and caps.
  • Miscellaneous: ensure non-obsolete status with OEM, keep to contract rates, and verify vendor code requirements.

Key Specifications

  • Wide range of oncology and supportive care pharmaceuticals (injectables and tablets)

  • Data Sheet submission mandatory for each offered item

  • 3 years govt/PSU supply experience for bidder or OEM

  • OEM authorization required for non-manufacturer bidders

  • GST registration and EFT mandate documentation

  • 25% quantity variation rights with delivery timeline adjustments

Terms & Conditions

  • Key Term 1: Quantity may vary ±25% at contract placement and during currency

  • Key Term 2: Bidder must retain 3 years residual market life for offered products

  • Key Term 3: Provide Data Sheets, GST/EFT documents and OEM authorization

Important Clauses

Payment Terms

GST payable as actuals or applicable rates; reimbursement as per rates; no explicit EMI term provided

Delivery Schedule

Delivery period starts from the last date of original delivery order; extended period for option quantity follows a defined formula with minimum 30 days

Penalties/Liquidated Damages

Not specified in the provided terms; bidders should seek explicit LD terms during clarification

Bidder Eligibility

  • 3 years of regular manufacturing/supply to Central/State Govt/PSU for similar products

  • OEM authorization or distributor authorization with complete contact details

  • GST registration and ability to upload GST data on GeM portal

Tender Data

Bid Details

Quantity

76124

Category

DOCETAXEL 20MG 0 point 5 ML VIAL PLUS 1 POINT 5 ML SOLVENT FOR INJ

Bid Type

Two Packet Bid

Bid Validity

180 (Days)

Bid Type

Service

Evaluation

Item wise evaluation

Inspection Required

No

RA Qualification Rule

H1-Highest Priced Bid Elimination

Tech Clarification Time

4 Days

Preference & Exemptions

EMD Required

No

MII Purchase Preference

Yes

MII Preference Band

L1+20%

MSE Purchase Preference

Yes

MSE Preference Band

L1+15%

MSE Exemption/Relaxation

No

Startup Exemption/Relaxation

Yes

Bid Splitting Applied

No

Requirements

Past Performance

60 %

Arbitration Clause

No

Mediation Clause

No

Additional Tender Data

Commercial Details

Tender Category

Goods

Bid To RA

No

Bid To RA Enabled

Yes

Item Category

DOCETAXEL 20MG 0 point 5 ML VIAL PLUS 1 POINT 5 ML SOLVENT FOR INJ , GRANULOCYTE COLONY STIMULATING FACTOR 300MCG INJ , IRINOTECAN 100MG INJ , Pegylated GCSF 6 mg Inj , Pembrolizumab Vial of 100 mg Inj , SUNITINIB 50 MG CAP , GEFITINIB 250MG TAB , 5- Fluorouracil 500mg 10 ml Inj , BENDAMUSTINE 100 MG INJ , TRANS DERMA PATCH BUPRENORPHINE EP 20 MG , CYTOSINE ARABINOSIDE 1000 MG INJ VIAL OF10 ML , DEGARELIX 120 MG INJ , DEGARELIX 80 MG INJ , DOXORUBICIN HCL 2MG OR ML 5ML INJ , Doxorubicin HCl Inj 2mg OR ml 25 ml Inj , EPIRUBICIN HCL 10 MG INJ , EPIRUBICIN HCL 50 MG INJ , ERIBULIN MESYLATE 1 MG OR 2ML INJ , ETOPOSIDE 100MG 5 ML INJ , GEMCITABINE 1000MG INJ , Pemetrexed 500 mg powder for injection , Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna , Leucovorin Calcium 50mg Inj , Inj LEUPROLIDE PFS OR Vial of 22 POINT 5 mg , Mesna 200mg Inj , METHOTREXATE 1000 MG INJ , METHOTREXTE 500 MG INJ , NANO ALBUMIN BOUND PACLITAXEL 100 MG INJ , NON CORING CHEMO PORT NEEDLE 20 G , OXALIPLATIN 100MG INJ , OXALIPLATIN 50MG INJ , PACLITAXEL 100MG INJ , PACLITAXEL 30MG INJ , Tab NETUPITANT PLUS PALOANOSETRONE , RASBURICASE 1 POINT 5 MG INJ , TOPOTECAN 2 POINT 5 MG INJ , VINBLASTINE SULPHATE 10 MG INJ , VINCRISTINE SULPHATE 1MG INJ , Zoledronic Acid 4 mg powder for Inj , ETOPOSIDE 50MG CAP , LENALIDOMIDE 10 MG CAP , Leucoverin 15 mg Tab , MEGESTEROL ACETATE 40MG TAB , MORPHINE HYDROCHLORIDE 30 MG TAB , Sorafenib 200mg Tab , Tab Alpelisib 150 mg , Tab Dabrafenib 75mg , Tab Lenalidomide 25 mg , TAB TRAMETINIB 2MG , TAB TRIFLURIDINE 8 POINT 19 MG PLUS TIPIRACIL 20 MG , Tegafur 100 mg PLUS Uracil 224 mg Cap , TEMOZOLAMIDE 100MG CAP , TEMOZOLAMIDE 250MG CAP , CAPECITABINE 500 MG TAB , VINORELBINE 50 MG INJ

Advisory Bank

State Bank of India

ePBG Percentage

3%

ePBG Duration (Months)

5

Delivery Details

Max Delivery Days

30

Delivery Locations

1

Delivery Cities

PUNE CITY

Delivery Locations

ConsigneeAddressCityStatePincodeQuantityDelivery DaysAdditional Requirement
-PUNE CITYPUNE CITY--10030-

Authority Records

MINISTRY OF DEFENCEMILITARY AFFAIRS DEPARTMENT

BID & GeM Expert Consultancy

End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.

Bid Preparation GeM Registration Document Filing

Free consultation · 24h response

Documents 5

GeM-Bidding-9740786.pdf

Main Document

BOQ Document

BOQ

BOQ Document

BOQ

Buyer uploaded ATC document

ATC

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Authority & Contact

Organization

Indian Army

Office Name

Not disclosed yet

Grievance Contact

[email protected]

Corrigendum Updates

1 Update
#1

Update

11-Sep-2026

Extended Deadline

14-Sep-2026, 5:30 am

Opening Date

15-Sep-2026, 5:30 am

Bill of Quantities (BOQ) 55 Items Sign in for GEM prices

#1

DOCETAXEL 20MG 0 point 5 ML VIAL PLUS 1 POINT 5 ML SOLVENT FOR INJ

DOCETAXEL 20MG 0 point 5 ML VIAL PLUS 1 POINT 5 ML SOLVENT FOR INJ

100 amp or vial Delivery: 30 days
#2

GRANULOCYTE COLONY STIMULATING FACTOR 300MCG INJ

GRANULOCYTE COLONY STIMULATING FACTOR 300MCG INJ

900 pfs Delivery: 30 days
#3

IRINOTECAN 100MG INJ

IRINOTECAN 100MG INJ

120 amp or vial Delivery: 30 days
#4

Pegylated GCSF 6 mg Inj

Pegylated GCSF 6 mg Inj

300 pfs or pfp Delivery: 30 days
#5

Pembrolizumab Vial of 100 mg Inj

Pembrolizumab Vial of 100 mg Inj

56 vial Delivery: 30 days
#6

SUNITINIB 50 MG CAP

SUNITINIB 50 MG CAP

540 no Delivery: 30 days
#7

GEFITINIB 250MG TAB

GEFITINIB 250MG TAB

2,400 no Delivery: 30 days
#8

5-Fluorouracil 500mg 10 ml Inj

5-Fluorouracil 500mg 10 ml Inj

862 amp or vial Delivery: 30 days
#9

BENDAMUSTINE 100 MG INJ

BENDAMUSTINE 100 MG INJ

72 vial Delivery: 30 days
#10

TRANS DERMA PATCH BUPRENORPHINE EP 20 MG

TRANS DERMA PATCH BUPRENORPHINE EP 20 MG

683 no Delivery: 30 days
#11

CYTOSINE ARABINOSIDE 1000 MG INJ VIAL OF10 ML

CYTOSINE ARABINOSIDE 1000 MG INJ VIAL OF10 ML

60 vial Delivery: 30 days
#12

DEGARELIX 120 MG INJ

DEGARELIX 120 MG INJ

36 vial Delivery: 30 days
#13

DEGARELIX 80 MG INJ

DEGARELIX 80 MG INJ

36 vial Delivery: 30 days
#14

DOXORUBICIN HCL 2MG OR ML 5ML INJ

DOXORUBICIN HCL 2MG OR ML 5ML INJ

240 amp or vial Delivery: 30 days
#15

Doxorubicin HCl Inj 2mg OR ml 25 ml Inj

Doxorubicin HCl Inj 2mg OR ml 25 ml Inj

300 amp or vial Delivery: 30 days
#16

EPIRUBICIN HCL 10 MG INJ

EPIRUBICIN HCL 10 MG INJ

300 amp or vial Delivery: 30 days
#17

EPIRUBICIN HCL 50 MG INJ

EPIRUBICIN HCL 50 MG INJ

180 amp or vial Delivery: 30 days
#18

ERIBULIN MESYLATE 1 MG OR 2ML INJ

ERIBULIN MESYLATE 1 MG OR 2ML INJ

30 no Delivery: 30 days
#19

ETOPOSIDE 100MG 5 ML INJ

ETOPOSIDE 100MG 5 ML INJ

150 amp or vial Delivery: 30 days
#20

GEMCITABINE 1000MG INJ

GEMCITABINE 1000MG INJ

480 amp or vial Delivery: 30 days
#21

Pemetrexed 500 mg powder for injection

Pemetrexed 500 mg powder for injection

180 vial Delivery: 30 days
#22

Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna

Ifosfamide Inj 1g vial with 3 amp of 2 ml each Mesna

180 vial Delivery: 30 days
#23

Leucovorin Calcium 50mg Inj

Leucovorin Calcium 50mg Inj

1,080 amp or vial Delivery: 30 days
#24

Inj LEUPROLIDE PFS OR Vial of 22 POINT 5 mg

Inj LEUPROLIDE PFS OR Vial of 22 POINT 5 mg

54 amp or vial Delivery: 30 days
#25

Mesna 200mg Inj

Mesna 200mg Inj

600 amp or vial Delivery: 30 days
#26

METHOTREXATE 1000 MG INJ

METHOTREXATE 1000 MG INJ

30 vial Delivery: 30 days
#27

METHOTREXTE 500 MG INJ

METHOTREXTE 500 MG INJ

30 vial Delivery: 30 days
#28

NANO ALBUMIN BOUND PACLITAXEL 100 MG INJ

NANO ALBUMIN BOUND PACLITAXEL 100 MG INJ

120 vial Delivery: 30 days
#29

NON CORING CHEMO PORT NEEDLE 20 G

NON CORING CHEMO PORT NEEDLE 20 G

750 no Delivery: 30 days
#30

OXALIPLATIN 100MG INJ

OXALIPLATIN 100MG INJ

175 amp or vial Delivery: 30 days
#31

OXALIPLATIN 50MG INJ

OXALIPLATIN 50MG INJ

360 amp or vial Delivery: 30 days
#32

PACLITAXEL 100MG INJ

PACLITAXEL 100MG INJ

240 amp or vial Delivery: 30 days
#33

PACLITAXEL 30MG INJ

PACLITAXEL 30MG INJ

240 amp or vial Delivery: 30 days
#34

Tab NETUPITANT PLUS PALOANOSETRONE

Tab NETUPITANT PLUS PALOANOSETRONE

240 no Delivery: 30 days
#35

RASBURICASE 1 POINT 5 MG INJ

RASBURICASE 1 POINT 5 MG INJ

30 amp Delivery: 30 days
#36

TOPOTECAN 2 POINT 5 MG INJ

TOPOTECAN 2 POINT 5 MG INJ

30 amp or vial Delivery: 30 days
#37

VINBLASTINE SULPHATE 10 MG INJ

VINBLASTINE SULPHATE 10 MG INJ

60 amp or vial Delivery: 30 days
#38

VINCRISTINE SULPHATE 1MG INJ

VINCRISTINE SULPHATE 1MG INJ

150 amp or vial Delivery: 30 days
#39

Zoledronic Acid 4 mg powder for Inj

Zoledronic Acid 4 mg powder for Inj

450 amp or vial Delivery: 30 days
#40

ETOPOSIDE 50MG CAP

ETOPOSIDE 50MG CAP

600 no Delivery: 30 days
#41

LENALIDOMIDE 10 MG CAP

LENALIDOMIDE 10 MG CAP

6,090 no Delivery: 30 days
#42

Leucoverin 15 mg Tab

Leucoverin 15 mg Tab

1,860 no Delivery: 30 days
#43

MEGESTEROL ACETATE 40MG TAB

MEGESTEROL ACETATE 40MG TAB

6,120 no Delivery: 30 days
#44

MORPHINE HYDROCHLORIDE 30 MG TAB

MORPHINE HYDROCHLORIDE 30 MG TAB

9,306 no Delivery: 30 days
#45

Sorafenib 200mg Tab

Sorafenib 200mg Tab

3,000 no Delivery: 30 days
#46

Tab Alpelisib 150 mg

Tab Alpelisib 150 mg

720 no Delivery: 30 days
#47

Tab Dabrafenib 75mg

Tab Dabrafenib 75mg

720 no Delivery: 30 days
#48

Tab Lenalidomide 25 mg

Tab Lenalidomide 25 mg

1,127 no Delivery: 30 days
#49

TAB TRAMETINIB 2MG

TAB TRAMETINIB 2MG

270 no Delivery: 30 days
#50

TAB TRIFLURIDINE 8 POINT 19 MG PLUS TIPIRACIL 20 MG

TAB TRIFLURIDINE 8 POINT 19 MG PLUS TIPIRACIL 20 MG

720 no Delivery: 30 days
#51

Tegafur 100 mg PLUS Uracil 224 mg Cap

Tegafur 100 mg PLUS Uracil 224 mg Cap

2,400 no Delivery: 30 days
#52

TEMOZOLAMIDE 100MG CAP

TEMOZOLAMIDE 100MG CAP

600 no Delivery: 30 days
#53

TEMOZOLAMIDE 250MG CAP

TEMOZOLAMIDE 250MG CAP

230 no Delivery: 30 days
#54

CAPECITABINE 500 MG TAB

CAPECITABINE 500 MG TAB

29,502 no Delivery: 30 days
#55

VINORELBINE 50 MG INJ

VINORELBINE 50 MG INJ

15 amp or vial Delivery: 30 days

Categories 9

🤖 AI-Powered Bidder Prediction

Discover companies most likely to bid on this tender

Live AI
Historical Data

Required Documents

1

Copy of PAN Card

2

Copy of GSTIN

3

Cancelled Cheque

4

Copy of EFT Mandate certified by Bank

5

Data Sheet of offered products

6

OEM Manufacturer Authorization/Distributorship certificate

7

Contracts/POs for similar Govt/PSU supplies (3 years back to bid opening)

8

GST upload on GeM portal (scanned copy)

Frequently Asked Questions

Key insights about MAHARASHTRA tender market

How to bid in Indian Army pharma tender 2026 with 3 years govt experience

Bidders must show at least 3 years of supplying similar Category Products to Central/State Govt or PSU, provide relevant contract copies, and attach OEM authorization if acting through a distributor. Include Data Sheets for each product and GST/EFT documents. The tender allows ±25% quantity variation and requires GST compliance on GeM.

What documents are required for pharma bid submission in this tender

Required documents include PAN Card, GSTIN, cancelled cheque, EFT Mandate, OEM authorization, product Data Sheets, and contracts/curchase orders proving 3-year govt supply experience. Upload GST on GeM and ensure Data Sheets match offered parameters; non-compliance risks rejection.

What is the quantity variation clause in this Indian Army tender

The purchaser may increase or decrease quantity by up to 25% of the bid quantity at contract placement and during the contract currency. Delivery extensions are calculated using a formula: (increased quantity/original quantity) × original delivery period, with a minimum of 30 days.

Which products require OEM authorization in this procurement

Where bidders are not the manufacturer, an OEM Authorization Form/certificate with full contact details is required. This ensures supply continuity and validates that the bidder has rights to offer the listed pharmacological items in government contracts.

What are the GST implications for this pharma procurement

GST is payable per actuals or applicable rates, whichever is lower, with reimbursement subject to quoted GST percentage. Bidders must ensure GSTIN validity and upload GST details on the GeM portal as part of submission.

What are the key technical data requirements for this tender

Bidders must upload Data Sheets for all offered products and ensure they align with parameters in the bid. Data Sheet mismatches can lead to bid rejection; ensure product specifications, strength, and packaging match the submission.

When is the delivery period and how is it calculated

Delivery starts after the last date of the original delivery order. If option quantity is exercised, additional time uses the formula: (Increased quantity ÷ Original quantity) × Original delivery period, with a minimum 30 days; the purchaser may extend within contract norms.

What is the scope of items in the BOQ for this tender

The BOQ comprises 55 items including a broad spectrum of oncology drugs, antiemetics, hormone therapies, patches, and supportive care medicines; item specifics are not listed in the provided data, but the category covers a wide pharmaceutical spectrum.